Trials / Withdrawn
WithdrawnNCT00515684
Corneal Thinning During Topical Bevacizumab Therapy
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bevacizumab (Avastin) |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2007-08-14
- Last updated
- 2015-05-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00515684. Inclusion in this directory is not an endorsement.